tiprankstipranks
Inozyme Pharma (INZY)
NASDAQ:INZY
US Market

Inozyme Pharma (INZY) Income Statement

Compare
730 Followers

Inozyme Pharma Income Statement

Last quarter (Q3 2024), Inozyme Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Inozyme Pharma's net income was $-24.57M. See Inozyme Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.29M$ -1.18M$ -1.05M$ -217.00K$ -83.00K
Operating Expenses
$ 75.64M$ 68.67M$ 56.65M$ 57.04M$ 20.81M
Depreciation and Amortization
$ 833.00K$ 1.18M$ 1.05M$ 217.00K$ 83.00K
EBITDA
$ -74.81M$ -65.88M$ -55.97M$ -56.82M$ -20.72M
Operating Income
$ -75.64M$ -68.67M$ -56.65M$ -57.04M$ -20.81M
Other Income/Expenses
$ 4.48M$ 1.61M$ 22.00K$ 617.00K$ 1.08M
Pretax Income
$ -71.17M$ -67.06M$ -56.62M$ -56.42M$ -19.72M
Net Income
$ -71.17M$ -65.45M$ -56.41M$ -55.84M$ -18.62M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.37$ -1.73$ -2.39$ -2.39$ -1.23
Diluted EPS
$ -1.37$ -1.73$ -2.39$ -2.39$ -1.23
Weighted Average Shares Outstanding
51.84M 37.76M 23.56M 23.38M 15.16M
Weighted Average Shares Outstanding (Diluted)
51.84M 37.76M 23.56M 23.38M 15.16M
Currency in USD

Inozyme Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis